Monday Morning Oncology Journal Club
3455 321
7:30-8:30 AM
CHOMP
Medical Staff Conference Room #1
Jan 6 Myeloma: Reviewing a Bispecific Antibody in Refractory Disease
“Teclistamab in Relapsed or Refractory Multiple Myeloma”
Moreau P, Garfall A, van de Donk N et al. NEJM June 5th, 2022
-Jenna Weatherson
Jan 13 Myeloma: Should We Treat Smoldering Disease?
“Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma”
Dimopoulos M, Voorhees P, Schjesvold F and the AQUILA Investigators NEJM December 9, 2024
-John Hausdorff
Jan 20 MLK Jr. Day
No Journal club
Jan 27 End of Life Option Act: Our 8 year experience from 2016-2024
-John Hausdorff